Aeglea BioTherapeutics Inc. (AGLE) slipped -7.53% or -0.66 to $8.11. It is approximately 560773 shares traded, which is 234.03% compare to the average total volume 239612. The market cap of AGLE is $233.73 million. The year to date change is 1.55%. The 52 week price range is from $6.31 to $12.0. Price of AGLE have changed 9.62% during last week. It have changed 3.79% over last month, 4.78% over last 3 months, -10.42% over last 6 months and -10.42% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 8.29. It is 2.22% above current price. The 200-day Moving Averages for AGLE is 8.83. It is 8.88% above current price. The 52-week High is 12.0. It is 47.97% from the current price. The 52-week Low is 6.31. It is -22.19% from current price.
There are some statistics of AGLE. It is has market cap $233.73 million. The share outstanding is 28.82 million. The average volume is 239612. The percent of top 15 Institution holding is 67.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -75.32%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -66.28%.